Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Aug 2022	37	Global Markets Direct	ASDR-609057

Published: Aug 2022 - Pages : 37 - Publisher : Global Markets Direct - Report code : ASDR-609057

Landsteiner Genmed SL
Oncotelic Therapeutics Inc
Phelix Therapeutics LLC
Selva Therapeutics Inc
Sorrento Therapeutics Inc